Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M8,665Revenue $M4,003Net Margin (%)-0.2Z-Score3.2
Enterprise Value $M9,767EPS $-0.1Operating Margin %0.4F-Score6
P/E(ttm))63.9Cash Flow Per Share $4.7Pre-tax Margin (%)-3.1Higher ROA y-yY
Price/Book2.910-y EBITDA Growth Rate %-8.7Quick Ratio1.6Cash flow > EarningsY
Price/Sales2.15-y EBITDA Growth Rate %-28.0Current Ratio2.6Lower Leverage y-yN
Price/Cash Flow6.8y-y EBITDA Growth Rate %250ROA % (ttm)-0.1Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-0.3Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M167ROI % (ttm)-1.9Gross Margin Increase y-yY

Gurus Latest Trades with HSP

Number of guru portfolios checked: 56.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
HSPVanguard Health Care Fund 2014-03-31 Add0.18%$40.89 - $45
($42.83)
$ 51.8421%Add 22.69%8,375,170
HSPMario Gabelli 2014-03-31 Add0.01%$40.89 - $45
($42.84)
$ 51.8421%Add 30.68%153,770
HSPMichael Price 2013-03-31 Add0.65%$28.96 - $35.99
($32.42)
$ 51.8460%Add 61.62%400,000
HSPVanguard Health Care Fund 2013-03-31 Add0.62%$28.96 - $35.99
($32.42)
$ 51.8460%Add 242.15%6,826,070
HSPMeridian Funds 2013-03-31 Buy 0.28%$28.96 - $35.99
($32.42)
$ 51.8460%New holding, 237400 sh.237,400
HSPMario Gabelli 2013-03-31 Add0.01%$28.96 - $35.99
($32.42)
$ 51.8460%Add 124.92%107,130
HSPMario Gabelli 2012-06-30 Add$31.2 - $37.29
($33.76)
$ 51.8454%Add 60.16%41,530
HSPMario Gabelli 2012-03-31 Add0.01%$30.14 - $38.14
($32.94)
$ 51.8457%Add 268.85%25,930
HSPJean-Marie Eveillard 2012-03-31 Sold Out -0.09%$30.14 - $38.14
($32.94)
$ 51.8457%Sold Out0
HSPRonald Muhlenkamp 2012-03-31 Sold Out -0.09%$30.14 - $38.14
($32.94)
$ 51.8457%Sold Out0
HSPMichael Price 2011-12-31 Buy 1.2%$27.29 - $38.76
($31.5)
$ 51.8465%New holding, 237500 sh.237,500
HSPVanguard Health Care Fund 2011-12-31 Add0.16%$27.29 - $38.76
($31.5)
$ 51.8465%Add 91.32%2,095,070
HSPJean-Marie Eveillard 2011-12-31 Buy 0.09%$27.29 - $38.76
($31.5)
$ 51.8465%New holding, 650013 sh.650,013
HSPMario Gabelli 2011-12-31 Buy $27.29 - $38.76
($31.5)
$ 51.8465%New holding, 7030 sh.7,030
HSPRonald Muhlenkamp 2011-12-31 Reduce-1.4%$27.29 - $38.76
($31.5)
$ 51.8465%Reduce -91.31%14,650
HSPMeridian Funds 2011-12-31 Sold Out -0.23%$27.29 - $38.76
($31.5)
$ 51.8465%Sold Out0
HSPMeridian Funds 2011-09-30 Add0.21%$34.44 - $54.22
($46.01)
$ 51.8413%Add 1019.87%169,100
HSPRonald Muhlenkamp 2011-09-30 Reduce-0.93%$34.44 - $54.22
($46.01)
$ 51.8413%Reduce -36.56%168,510
HSPGeorge Soros 2011-09-30 Sold Out -0.0798%$34.44 - $54.22
($46.01)
$ 51.8413%Sold Out0
HSPMeridian Funds 2011-06-30 Buy 0.03%$53.74 - $58.13
($55.51)
$ 51.84-7%New holding, 15100 sh.15,100
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

HSP is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
HSP Mario Gabelli 2014-03-31153,7700.090.04+30.68%
HSP Vanguard Health Care Fund 2014-03-318,375,1705.011+22.69%
HSP Michael Price 2014-03-31400,0000.242.1
HSP Meridian Funds 2013-06-30257,4000.150.37+8.42%
Premium Most recent portfolio changes are included for Premium Members only!


HSP: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Werner Thomas ESVP, Finance & CFO 2014-07-15Sell10,000$51.50.43view
Werner Thomas ESVP, Finance & CFO 2014-06-16Sell10,000$50.821.77view
Werner Thomas ESVP, Finance & CFO 2014-05-21Sell30,000$47.987.79view
CURRAN CONNIE RDirector 2014-05-16Sell2,000$47.449.02view
BOWLES BARBARA LDirector 2014-05-14Sell2,000$47.778.27view
Hoffman Richard JCVP, Controller & CAO 2014-05-13Sell15,000$48.077.59view
SMITH BRIAN JSVP and Special Counsel 2014-05-12Sell40,000$487.75view
Stober Matthew RSVP, Operations 2014-03-14Sell19,217$42.2822.33view
Werner Thomas ESVP, Finance & CFO 2014-02-26Sell20,000$42.5321.61view
Hoffman Richard JCVP, Controller & CAO 2013-09-11Sell9,850$39.3831.34view

Press Releases about HSP :

    Quarterly/Annual Reports about HSP:

    News about HSP:

    Articles On GuruFocus.com
    Brian Rogers' T. Rowe Price Equity Income Fund Semi-Annual Report 2013 Dec 02 2013 
    Ariel Capital's John Rogers Trims Sotheby’s, DeVry, Hospira, IPG, Others Nov 18 2013 
    Five Companies Cut - Pzena Investment Management Update Nov 12 2013 
    John Rogers Comments on Hospira Inc. Jul 25 2013 
    Rowe Price Equity Income Fund Buys Apple, Carnival, Joy Global, Sells Thermo Fisher, Energizer, SLM Jul 19 2013 
    John Rogers Ariel Fund Second Quarterly Commentary Jul 18 2013 
    Brian Rogers' Top 3 Increases and Decreases of Q2 Jul 17 2013 
    comment on HSP May 22 2013 
    Brian Rogers of T Rowe Price Buys 4 New Stocks, Including Apple in Q1 Apr 17 2013 
    Weekly Guru Bargains Highlights: SOHU, NFG, CHK, HSP, PT Feb 10 2012 


    More From Other Websites
    The Morning Ledger: Former Treasury Official: White House Could Curb Inversions Alone Jul 28 2014
    [$$] Hospira May Buy Danone Medical-Nutrition Unit for $5 Billion Jul 28 2014
    PRESS DIGEST - Wall Street Journal - July 28 Jul 27 2014
    Hospira and Danone in Talks on $5 Billion Inversion Deal Jul 27 2014
    PRESS DIGEST- Financial Times - July 28 Jul 27 2014
    Europe midday: Stocks little changed on quiet start to the week Jul 27 2014
    Danone Said in Talks to Sell Its Medical Unit to Hospira Jul 27 2014
    St. Jude Medical Gets CE Mark for FlexAbility Catheter Jul 24 2014
    Hospira Upgraded to Strong Buy on Orchid Facility Buy Jul 15 2014
    Hospira Completes Orchid Facility Buy Jul 07 2014
    Hospira completes acquisition of Orchid's API facility Jul 06 2014
    Hospira Completes Acquisition of Orchid's Active Pharmaceutical Ingredient Manufacturing and R&D... Jul 04 2014
    Hospira Completes Acquisition of Orchid's Active Pharmaceutical Ingredient Manufacturing and R&D... Jul 04 2014
    Hospira to Host Conference Call for Second-Quarter 2014 Results Jul 01 2014
    Hospira to Host Conference Call for Second-Quarter 2014 Results Jul 01 2014
    America's top states for innovation Jun 24 2014
    Hospira Statement Regarding Paclitaxel Supply and Pricing Jun 06 2014
    Insider Trading Alert - SCG, PRI And HSP Traded By Insiders May 20 2014
    Hospira targets FY18 top line growth in the mid-to-high single digits May 14 2014
    HOSPIRA INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders May 12 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Email Hide